Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by sandysoucion Oct 20, 2020 12:13pm
295 Views
Post# 31748379

RE:DEVELOPMENTS

RE:DEVELOPMENTSthis is a MUST READ POST, thanks very much whatdoiknow!... excellent summary of recent events...

whatdoiknow123 wrote: Comments on events of last few days:

1. The most important I would suggest is that the notification of change to " awaiting info from manufacturers" was on  Friday Oct 16th. This info was forthcoming, and change on web once again to "under review",on Monday 19th, that is less than 2 working days later. That would suggest that the info requested was quite simple and straightforward receiving an almost instantaneous response from SONA. In my opinion that bodes well for a likely Approval very soon.
2. The jump in share price late yesterday tends to confirm that opinion.
3. The significant drop in SP on Friday was likely PIs worried about a significant delay,given the notification change, selling and putting their money elsewhere. The volume was not high and, in my opinion, not suggestive of anything more worrying.
4. efre16 posts on the Abbott BinaxNOW test and it´s "new" app and asks whether SONA can beat that. Well, frankly, the answer is yes. SONA is the only Antigen LFA  test that has shown effectivety in the Asymptomatic and is 3rd Party Validated. The Abbott test has NOT  been 3rd Party Validated, has had it´s Sensitivity called into question on several occasions, including by the FDA publically and has evidence only for good effectivety in the well-established patients with high-viral loads.
The app that they boast about does not in any way compare with the system that BOND and SONA have developed. The Abbott app is simply confirmation of the test result, rather like a signed piece of paper but displayed on your mobile. No more, no less.
The BOND/SONA app is far more sophisticated and useful.It automatically notifies the relevant Health Authorities directly of the test results, patient´s details and health status, patient´s location and many other details in order to allow those Authorities to map the virus hot spots, study it´s spread, help contact tracing etc. 
The BOND/ SONA app is the type of system that the FDA has insisted must be in place before they will allow home testing.
5. Creesil questions the type of Approval that will be granted. It will almost certainly be similar to that granted to Abbott and no, that will not be a  "kick in the crotch". It will be exactly what SONA  need to get mass-manufacturing and sales moving which will, in turn, cause the SP to reflect this new situation. Saliva and home-testing  will be 2.0 and 3.0 and are almost certainly be being worked on as we speak.
6. It should be remembered that there will more than enough demand to go around for some time to come. Abbott are building 2 new factories only to meet part of the demand that they admit they can nowhere near meet. The UK alone has planned a 170 billion $Can testing programme and is inviting bids to manage this for 18-24 months minimum.
7. the development of a vaccine will hopefully be successful, but it will be a very long time before enough people can be vaccinated to limit the spread. Testing will be required for quite a while yet, probably for much longer than most people think and there will be enough time for all Companies with a successful test to do very well.

Hopefully all will start becoming clearer very soon with a step by step progress report to come over the following months on sales, further Approvals, new and improved tests etc. 


<< Previous
Bullboard Posts
Next >>